CaReMe Pro Series: Practical Decisions for Complex Patients

Free CME-Accredited Program | 3 Activities | Up to 3.5 CME Credits

Cardio-renal-metabolic (CaReMe) syndrome represents a growing clinical challenge, driven by the complex interplay between heart failure (HF), chronic kidney disease (CKD), and metabolic disorders such as diabetes and obesity. These interconnected conditions demand early recognition, evidence-based treatment, and strong multidisciplinary collaboration to improve patient outcomes.

CaReMe Pro Series: Practical Decisions for Complex Patients is a free, CME-accredited program designed to support healthcare professionals in navigating this complexity. Through microlearning, interactive case-based education, and expert-led discussions, this program provides practical tools to enhance decision-making across the continuum of care.

This program is supported by an educational grant from Boehringer Ingelheim.

What This Program Offers

3 On-Demand Learning Activities

Up to 3.5 CME Credits

Case-Based & Expert-Led Content

Flexible Learning for Busy HCPs

Early Recognition: Understanding CaReMe Syndrome

Interactive Microlearning Series | 1 CME Credit

This bite-sized, expert-led microlearning series delivers essential insights into the early recognition and diagnosis of CaReMe syndrome. Through four concise modules, each under 15 minutes, clinicians can quickly build foundational knowledge and apply it in practice.

Designed for flexibility, this activity combines short video lessons with reflective questions, allowing learners to engage at their own pace. Participants can also join a live “Meet the Expert” session to deepen their understanding and discuss real-world challenges.

Module Highlights

Module 1: Pathophysiological Overlap Between HF and CKD
Explore the biological mechanisms linking heart and kidney dysfunction and their impact on patient outcomes.

Module 2: Biomarkers for Early Diagnosis
Learn how to identify and apply key biomarkers in early-stage disease detection.

Module 3: Risk Factors and Comorbidities
Examine the role of diabetes, obesity, and other comorbidities in disease progression and prevention.

Module 4: Identifying High-Risk Patients
Develop skills to recognize clinical signs and improve early intervention strategies.


✔️ Ideal for: Primary care physicians, general practitioners, nephrologists, cardiologists, and endocrinologists

LEARN MORE

Optimizing Treatment Strategies for Multimorbid Patients

Interactive Case-Based E-Learning | 1 CME Credit

This 60-minute interactive course focuses on the management of patients with coexisting HF and CKD. Through realistic patient scenarios, clinicians will strengthen their ability to apply guidelines and tailor treatments in complex, multimorbid cases.

Learners will engage with two detailed patient cases, make clinical decisions, and receive immediate feedback to reinforce practical understanding.

Learning Objectives

  • Summarize current guidelines for HFpEF, HFrEF, and CKD management
  • Evaluate patient data to guide treatment decisions
  • Compare benefits and risks of evidence-based therapies, including SGLT2 inhibitors and MRAs

✔️ Ideal for: Nephrologists, cardiologists, endocrinologists, and primary care physicians

LEARN MORE

Enhancing Multidisciplinary Collaboration in CaReMe Care

On-Demand Expert Webinar | 1.5 CME Credits

This expert-led webinar explores how multidisciplinary collaboration can transform outcomes for patients with CaReMe syndrome. Featuring internationally recognized specialists, the session provides actionable strategies to improve coordination across cardiology, nephrology, endocrinology, and primary care.

Learning Objectives

  • Strengthen collaboration across specialties in managing complex patients
  • Apply the latest evidence in cardiometabolic care
  • Identify opportunities for early intervention and integrated management

✔️ Ideal for: Primary care physicians, cardiologists, nephrologists, endocrinologists, and multidisciplinary teams

LEARN MORE

This program is supported by an educational grant from Boehringer Ingelheim.